Your Messages Inbox
Your Article Summary
See Latest ArticlesLundbeck recording growth in Spain - strong growth propels escitalopram to a market-leading position
Lundbeck, 07/06/09
Having achieved constant growth since its market launch, Lundbeck's successful pharmaceutical escitalopram is now the best-selling antidepressant in the important Spanish market. Lundbeck's recognised and widely available anti-depressant escitalopram is experiencing continuing growth and has now become the best-selling anti-depressant in the important Spanish market, the fourth-largest anti-depressants market in Europe. In terms of value, escitalopram now commands a little more than 22% of the market, which has a total value of about DKK 3.6bn annually.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/15/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09
Article Search
Sponsor